Centro Estatal de Cancerologia de Durango

Durango 34000

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Carcinoma, Non-small-cell Lung

Studies at this site

• A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer — Completed
• OSI-774 (Tarceva) in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer — Completed